Home
Our Focus
Overview
Literature & Publications
Pipeline
Overview
Acute Ischemic Stroke
Cardio-Renal Disease
Clinical Trials
Overview
Acute Ischemic Stroke
ReMEDy2
Overview
About ReMEDy2
Stroke Disease
For Physicians
Trial Locations
About DiaMedica
Overview
Leadership
Careers
Contact
Investors Relations
Overview
Press Releases
Events & Presentations
Stock Data
Analyst Coverage
Financial Reports & SEC Filings
Governance
Resources
SEC Filings
Investors Relations
Investors Relations
Overview
Press Releases
Events & Presentations
Stock Data
Nasdaq Quote
Charts
Historical Data
Analyst Coverage
Financial Reports & SEC Filings
SEC Filings
Annual Reports
Tax Information (PFIC)
Governance
Board of Directors
Board Committees
Governance Documents
Resources
Investor Contact
FAQ
Share Consolidation Instructions
Email Alerts
Financial Reports & SEC Filings
SEC Filings
Annual Reports
Tax Information (PFIC)
Filing Type:
View All
10-K
10-K/A
10-Q
20FR12B
20FR12B/A
3
4
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
REGDEX
RW
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2014
2007
Date
Form
Description
PDF
XBRL
Pages
11/09/18
S-1
General form of registration statement for all companies including face-amount certificate companies
Documents
EX-3.1
EX-3.2
EX-3.3
EX-3.5
EX-4.1
EX-4.2
EX-4.3
EX-4.4
EX-4.5
EX-4.6
EX-4.7
EX-4.8
EX-4.9
EX-4.10
EX-4.11
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-10.11
EX-10.12
EX-10.13
EX-10.14
EX-10.15
EX-21.1
EX-23.1
658
11/02/18
UPLOAD
SEC-generated letter
Documents
TEXT-EXTRACT
2
11/01/18
DRSLTR
Correspondence Related to Draft Registration Statement
2
11/01/18
DRS
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-3.1
EX-3.2
EX-3.3
EX-3.5
EX-4.1
EX-4.2
EX-4.3
EX-4.4
EX-4.5
EX-4.6
EX-4.7
EX-4.8
EX-4.9
EX-4.10
EX-4.11
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-10.5
EX-10.6
EX-10.7
EX-10.8
EX-10.9
EX-10.10
EX-10.11
EX-10.12
EX-10.13
EX-10.14
EX-10.15
EX-21.1
663
10/19/18
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-3.3
EX-3.6
EX-10.4
EX-10.12
EX-10.13
EX-10.14
EX-10.15
252
10/18/18
DRSLTR
Correspondence Related to Draft Registration Statement
5
10/15/18
UPLOAD
SEC-generated letter
Documents
TEXT-EXTRACT
3
09/17/18
DRSLTR
Correspondence Related to Draft Registration Statement
2
09/17/18
DRS/A
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Documents
EX-10.5
EX-10.6
169
09/04/18
UPLOAD
SEC-generated letter
Documents
TEXT-EXTRACT
2
Previous
1…
22
23
24
25
26
27
28
29
30
31
Next
Email Alerts
Contacts
RSS News Feed